These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
473 related articles for article (PubMed ID: 16221703)
1. The vitamin D prodrugs 1alpha(OH)D2, 1alpha(OH)D3 and BCI-210 suppress PTH secretion by bovine parathyroid cells. Brown AJ; Ritter CS; Knutson JC; Strugnell SA Nephrol Dial Transplant; 2006 Mar; 21(3):644-50. PubMed ID: 16221703 [TBL] [Abstract][Full Text] [Related]
2. 1Alpha,25-dihydroxy-3-epi-vitamin D3, a natural metabolite of 1alpha,25-dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion. Brown AJ; Ritter C; Slatopolsky E; Muralidharan KR; Okamura WH; Reddy GS J Cell Biochem; 1999 Apr; 73(1):106-13. PubMed ID: 10088729 [TBL] [Abstract][Full Text] [Related]
3. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis. Brandi L Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159 [TBL] [Abstract][Full Text] [Related]
4. Potentiating effects of nonactive/active vitamin D analogues and ketoconazole in parathyroid cells. Segersten U; Björklund P; Hellman P; Akerström G; Westin G Clin Endocrinol (Oxf); 2007 Mar; 66(3):399-404. PubMed ID: 17302875 [TBL] [Abstract][Full Text] [Related]
5. 25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells. Ritter CS; Armbrecht HJ; Slatopolsky E; Brown AJ Kidney Int; 2006 Aug; 70(4):654-9. PubMed ID: 16807549 [TBL] [Abstract][Full Text] [Related]
6. The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer. Chen TC; Schwartz GG; Burnstein KL; Lokeshwar BL; Holick MF Clin Cancer Res; 2000 Mar; 6(3):901-8. PubMed ID: 10741714 [TBL] [Abstract][Full Text] [Related]
7. Direct suppression of Pth gene expression by the vitamin D prohormones doxercalciferol and calcidiol requires the vitamin D receptor. Ritter CS; Brown AJ J Mol Endocrinol; 2011 Apr; 46(2):63-6. PubMed ID: 21169421 [TBL] [Abstract][Full Text] [Related]
9. Vitamin D metabolites do not alter parathyroid hormone secretion acutely. Magliola L; Anast CS; Forte LR Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783 [TBL] [Abstract][Full Text] [Related]
10. Comparison between 1alpha(OH)D3 and 1,25(OH)2D3 on the suppression of plasma PTH levels in uremic patients, evaluated by the 'whole' and 'intact' PTH assays. Brandi L; Egfjord M; Olgaard K Nephron Clin Pract; 2005; 99(4):c128-37. PubMed ID: 15722644 [TBL] [Abstract][Full Text] [Related]
11. 1α,24(S)(OH)2D2 normalizes bone morphology and serum parathyroid hormone without hypercalcemia in 25-hydroxyvitamin D-1-hydroxylase (CYP27B1)-deficient mice, an animal model of vitamin D deficiency with secondary hyperparathyroidism. St-Arnaud R; Arabian A; Yu VW; Akhouayri O; Knutson JC; Strugnell SA J Endocrinol Invest; 2008 Aug; 31(8):711-7. PubMed ID: 18852532 [TBL] [Abstract][Full Text] [Related]
12. Synthesis, stereochemistry, and biological activity of 1alpha,23,25-trihydroxy-24-oxovitamin D3, a major natural metabolite of 1alpha,25-dihydroxyvitamin D3. Lee NE; Reddy GS; Brown AJ; Williard PG Biochemistry; 1997 Aug; 36(31):9429-37. PubMed ID: 9235987 [TBL] [Abstract][Full Text] [Related]
14. A new analog of 1,25-(OH)2D3, 19-NOR-1,25-(OH)2D2, suppresses serum PTH and parathyroid gland growth in uremic rats without elevation of intestinal vitamin D receptor content. Takahashi F; Finch JL; Denda M; Dusso AS; Brown AJ; Slatopolsky E Am J Kidney Dis; 1997 Jul; 30(1):105-12. PubMed ID: 9214408 [TBL] [Abstract][Full Text] [Related]
15. Isolation and identification of 1alpha-hydroxy-3-epi-vitamin D3, a potent suppressor of parathyroid hormone secretion. Brown AJ; Ritter CS; Weiskopf AS; Vouros P; Sasso GJ; Uskokovic MR; Wang G; Reddy GS J Cell Biochem; 2005 Oct; 96(3):569-78. PubMed ID: 16088954 [TBL] [Abstract][Full Text] [Related]
16. The roles of calcium and 1,25-dihydroxyvitamin D3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Brown AJ; Zhong M; Finch J; Ritter C; Slatopolsky E Endocrinology; 1995 Apr; 136(4):1419-25. PubMed ID: 7895652 [TBL] [Abstract][Full Text] [Related]
17. Combined effects of dexamethasone and 1,25-dihydroxyvitamin D3 on parathyroid hormone secretion in cultured bovine parathyroid cells. Sugimoto T; Brown AJ; Ritter C; Morrissey J; Slatopolsky E; Martin KJ Endocrinology; 1989 Aug; 125(2):638-41. PubMed ID: 2546741 [TBL] [Abstract][Full Text] [Related]
18. Effects of vitamin D3, 25-hydroxyvitamin D3, and 24,25-dihydroxyvitamin D3 on parathyroid hormone secretion. Cantley LK; Russell JB; Lettieri DS; Sherwood LM Calcif Tissue Int; 1987 Jul; 41(1):48-51. PubMed ID: 3040201 [TBL] [Abstract][Full Text] [Related]
19. Interaction between calcium and 1,25-dihydroxyvitamin D3 in the regulation of preproparathyroid hormone and vitamin D receptor messenger ribonucleic acid in avian parathyroids. Russell J; Bar A; Sherwood LM; Hurwitz S Endocrinology; 1993 Jun; 132(6):2639-44. PubMed ID: 8389284 [TBL] [Abstract][Full Text] [Related]
20. Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. Silver J; Naveh-Many T; Mayer H; Schmelzer HJ; Popovtzer MM J Clin Invest; 1986 Nov; 78(5):1296-301. PubMed ID: 3771798 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]